Pay in 4 interest-free payments of $5.41 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Key takeaways Regulatory Status: As of April 2026, BPC-157 is classified as a Category 2 bulk drug substance by the FDA prohibited in compounding under Section 503A and 503B
Results in research may vary
So far so good Such fast shipping You guys are amazing from your amazing products to amazing response and service
Neurological Support and Nerve Repair BPC-157 demonstrates neuroprotective properties across traumatic brain injury, stroke, spinal cord injury, and peripheral nerve damage models
No study has linked them to tumor promotion, but if you have an active cancer, the theoretical risk of feeding blood vessels to it is worth taking seriously
Adding B12 to a doctor-approved weight loss plan offers great long-term advantages
